The ANZMUSC Working Group is composed of the following members:
Professor Rachelle Buchbinder (Chair)
Director, Monash Department of Clinical Epidemiology, Cabrini Hospital; Professor, Department of Epidemiology and Preventive Medicine, Monash University; and Coordinating Editor, Cochrane Musculoskeletal Group.
Rachelle Buchbinder is a rheumatologist/clinical epidemiologist and NHMRC Senior Principal Research Fellow. She has published the results of 17 randomised controlled trials, many in high impact journals including NEJM, JAMA, BMJ and Ann Rheum Dis. Seven of these were NHMRC-funded and another two NHMRC-funded trials are underway. She has published 42 Cochrane systematic reviews and another 16 are in progress. Her research also extends to development of new outcome measures and core sets of outcomes for clinical trials to facilitate pooling and comparison of data across trials.
Professor Ian Harris AM
Orthopaedic Surgeon, University of NSW.
Professor Ian Harris is Professor of Orthopaedic Surgery at UNSW. He maintains a clinical orthopaedic practice and directs a research unit based at Liverpool, in Sydney’s south west. His research activities include registries, clinical trials, systematic reviews and methodological studies in the fields of surgical outcomes, trauma (fractures), joint replacement surgery and rehabilitation after surgery. His aims are to improve the evidence base for orthopaedic surgery and to better align clinical practice with that evidence base.
Professor Jane Latimer
Principal Research Fellow and Deputy Director of the Musculoskeletal Division at The George Institute for Global Health and a Professor in the Sydney Medical School at The University of Sydney.
Professor Jane Latimer is ARC Future Fellow who has conducted a number of large randomized controlled trials evaluating the management of spinal pain in primary care. She has published the findings of these in national and international peer-reviewed journals including the Lancet, JAMA and Arch Intern Med. She has obtained over $12.5 million to fund this work including 11 NHMRC project grants (2 of these currently underway), in addition to funding from industry, the federal government and philanthropy.
Professor Chris Maher
Director, Musculoskeletal Division, The George Institute for Global Health Professor, Sydney Medical School, The University of Sydney.
Professor Maher leads a research division focusing on the management of musculoskeletal conditions in primary care and community settings. Prof Maher’s research evaluates the primary care management of back pain and he holds an NHMRC Senior Research Fellowship. Prof Maher is a fellow of the Australian College of Physiotherapy and has degrees in physiotherapy and exercise science. Prof Maher has over 400 publications, $18Million in research funding and 28 PhD completions. He is on the editorial board of the Cochrane Back Review group, Associate Editor for Physical Therapy and a Steering Committee member for the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network.
Associate Professor Will Taylor
Rheumatologist and rehabilitation physician, University of Otago, New Zealand.
Will Taylor also has an academic appointment with the University of Otago where he is responsible for a postgraduate teaching programme in rehabilitation. His PhD concerned the classification criteria of psoriatic arthritis and his research interests remain in the broad field of clinical epidemiology, particularly health status measurement and diagnostic classification criteria. He has expertise in psychometrics, latent class analysis, the application of Rasch models to health status measures and is developing an interest in conjoint analysis of discrete choice experiments. He has over 100 peer-reviewed journal articles and an h-index of 34, with 14 publications that each have more than 80 citations.
He is currently involved with national and international collaborations particularly in the field of gout: validation of gout flare definitions, how gout flare rates are related to patients’ perceptions of disease control in gout, whether serum urate is an adequate surrogate for clinical outcomes in the context of clinical trials, application of the ICF to gout and development of valid criteria for remission from gout that could be used in outcome studies. He has recently completed an international project that re-defined the case-definition for gout sponsored by the American College of Rheumatology and European League Against Rheumatism. He has chaired the gout OMERACT group since 2010.
Dr Sam Whittle
Rheumatologist and clinical epidemiologist, Queen Elizabeth Hospital in Adelaide.
Dr Samuel Whittle is also a Senior Lecturer at the University of Adelaide. His research interests include fibromyalgia syndrome, chronic pain in inflammatory arthritis, spondyloarthritis and gout. He is currently involved in an NHMRC-funded trial investigating therapies for lateral epicondylitits, has 4 published Cochrane reviews (with another 3 in progress) and has been published in several top rheumatology and general medicine journals including JAMA, Arthritis & Rheumatism, Rheumatology and Annals of Internal Medicine.
Dr Bethan Richards
Staff Specialist Rheumatologist and Head of Rheumatology at Royal Prince Alfred Hospital, Sydney.
Dr Bethan Richards is also a Senior Clinical Lecturer with the University of Sydney. She is currently completing her PhD, has a CCPU (Musculoskeletal), Masters in Clinical Epidemiology and Sports Medicine, and is an OMERACT arthroplasty and ultrasound fellow. She is also the Rheumatology Series Editor, Medicine Today, and Rheumatology representative on the N.S.W Agency for Clinical Innovation’s Unwarranted Clinical Variation Taskforce. Dr Richards is currently an investigator on >10 randomised controlled trials, including an NHMRC-funded trial, and has published 4 Cochrane Systematic reviews with another two in progress.